Search by Drug Name or NDC

    NDC 00143-9517-01 Methotrexate 25 mg/mL Details

    Methotrexate 25 mg/mL

    Methotrexate is a INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is METHOTREXATE.

    Product Information

    NDC 00143-9517
    Product ID 0143-9517_3046ff78-3565-46d1-a88b-283e5ff6e7c3
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Methotrexate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Methotrexate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS
    Active Ingredient Strength 25
    Active Ingredient Units mg/mL
    Substance Name METHOTREXATE
    Labeler Name Hikma Pharmaceuticals USA Inc.
    Pharmaceutical Class Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA089342
    Listing Certified Through 2024-12-31

    Package

    NDC 00143-9517-01 (00143951701)

    NDC Package Code 0143-9517-01
    Billing NDC 00143951701
    Package 1 VIAL in 1 BOX (0143-9517-01) / 8 mL in 1 VIAL
    Marketing Start Date 2018-01-05
    NDC Exclude Flag N
    Pricing Information N/A